WVE Wave Life Sciences Ltd. - Ordinary Shares
$5,16
Cena · Sie 18, 2026
Dane fundamentalne na dzień Lip 30, 2026
Zakres 52 tyg.
$5–$21
1% of range
Ocena Analityków
BUY
20 analysts
Cena Docelowa
$19
+269% upside
P/E (TTM)
-14.0
ROE
—
Marża Zysku Netto
—
O Wave Life Sciences Ltd. - Ordinary Shares Przegląd firmy z Wikipedii
WVE Migawka akcji Cena, kapitalizacja rynkowa, P/E, EPS, ROE, zadłużenie/kapitał własny, zakres 52-tygodniowy
Cena
$5.16
Kapitalizacja Rynkowa
—
P/E (TTM)
-14.0
EPS (TTM)
$-1.21
Przychody (TTM)
$43M
Stopa dywidendy
—
ROE
—
D/E Dług/Kapitał
—
Zakres 52 tyg.
$5 – $21
WVE Wykres ceny akcji Dzienny OHLCV ze wskaźnikami technicznymi — przesuwaj, powiększaj i dostosowuj widok
Configure
Wyniki 10-letnie Trendy przychodów, zysku netto, marż i EPS
Przychody i Zysk Netto
$43M
2016-12-31
→
2025-12-31
EPS
$-1.21
2021-12-31
→
2025-12-31
Wolny przepływ pieniężny
—
Marże
—
Wycena Wskaźniki P/E, P/S, P/B, EV/EBITDA — czy akcje są drogie, czy tanie?
Wskaźnik
Trend 5-letni
WVE
Mediana porównawcza
P/E (TTM)
-14.0
19.5
Rentowność Marże brutto, operacyjne i netto; ROE, ROA, ROIC
Wskaźnik
Trend 5-letni
WVE
Mediana porównawcza
Zdrowie finansowe Dług, płynność, wypłacalność — siła bilansu
Wskaźnik
Trend 5-letni
WVE
Mediana porównawcza
Rozwój Wzrost przychodów, EPS i zysku netto: r/r, CAGR 3-letni, CAGR 5-letni
Wskaźnik
Trend 5-letni
WVE
Mediana porównawcza
Revenue YoY (Przychody R/R)
-60.6%
—
Revenue CAGR 3Y (Przychody CAGR 3L)
127.1%
—
Revenue CAGR 5Y (Przychody CAGR 5L)
16.3%
—
Efektywność kapitałowa Rotacja aktywów, rotacja zapasów, rotacja należności
Wskaźnik
Trend 5-letni
WVE
Mediana porównawcza
WVE Konsensus analityków Bycze i niedźwiedzie opinie analityków, 12-miesięczny cel cenowy, potencjał wzrostu
KUP
20 analityków
- Mocne kupno 6 30,0%
- Kup 13 65,0%
- Trzymaj 1 5,0%
- Sprzedaj 0 0,0%
- Mocna sprzedaż 0 0,0%
12-miesięczny cel cenowy
16 analityków · 2026-08-17
Mediana
$15.00
Średnia
$19.06
← Poniżej wszystkich celów
$5.16
Niski
$12.00
Wysoki
$42.00
Średni cel
$15.00
+190,7%
Średnia cel
$19.06
+269,4%
Historia zysków EPS faktyczny vs szacowany, zaskoczenie %, wskaźnik trafień, data następnych wyników
Średnie zaskoczenie
0.01%
| Okres | EPS Actual | EPS Szacowany | Niespodzianka |
|---|---|---|---|
| 30 czerwca 2026 | $-0.34 | $-0.31 | -0.03% |
| 31 marca 2026 | $-0.13 | $-0.33 | 0.20% |
| 31 grudnia 2025 | $-0.30 | $-0.27 | -0.03% |
| 30 września 2025 | $-0.32 | $-0.30 | -0.02% |
| 30 czerwca 2025 | $-0.31 | $-0.29 | -0.02% |
| 31 marca 2025 | $-0.29 | $-0.26 | -0.03% |
Pełne podstawowe wskaźniki Wszystkie wskaźniki roczne — rachunek zysków i strat, bilans, przepływy pieniężne
Rachunek zysków i strat 13
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $43M | $108M | $113M | $4M | $41M | $20M | $16M | $14M | $4M | $1M | $152.0K | |
| R&D Expense | $183M | $160M | $130M | $116M | $122M | $131M | $175M | $134M | $79M | $41M | $9M | |
| SG&A Expense | $75M | $59M | $51M | $51M | $46M | $43M | $49M | $40M | $27M | $16M | $10M | |
| Operating Expenses | $258M | $219M | $181M | $166M | $168M | $173M | $224M | $174M | $106M | $57M | $19M | |
| Operating Income | $-215M | $-110M | $-68M | $-163M | $-127M | $-153M | $-208M | $-160M | $-102M | $-56M | $-19M | |
| Other Non-op | $527.0K | $3M | $2M | $7.0K | $5M | $2M | $10M | $10M | $-331.0K | $-50.0K | $56.0K | |
| Pretax Income | $-204M | $-97M | $-58M | $-161M | $-122M | $-151M | $-194M | $-147M | $-101M | $-55M | $-19M | |
| Income Tax | $0 | $0 | $-677.0K | $681.0K | $-204.0K | $-841.0K | $0 | $69.0K | $842.0K | $482.0K | $44.0K | |
| Net Income | $-204M | $-97M | $-58M | $-162M | $-122M | $-150M | $-194M | $-147M | $-102M | $-56M | $-19M | |
| EPS (Basic) | $-1.21 | $-0.70 | $-0.54 | $-2.05 | $-2.36 | · | · | · | · | · | · | |
| EPS (Diluted) | $-1.21 | $-0.70 | $-0.54 | $-2.05 | $-2.36 | · | · | · | · | · | · | |
| Shares (Basic) | 168,649,795 | 138,277,468 | 106,097,268 | 78,855,810 | 51,825,566 | · | · | · | · | · | · | |
| Shares (Diluted) | 168,649,795 | 138,277,468 | 106,097,268 | 78,855,810 | 51,825,566 | · | · | · | · | · | · |
Bilans 23
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $602M | $302M | $200M | $88M | $151M | $184M | $147M | $175M | $143M | $150M | $161M | |
| Receivables | $1M | $1M | $21M | · | · | $30M | $20M | $10M | $1M | · | · | |
| Prepaid Expense | $8M | $10M | $10M | $8M | $7M | $10M | $10M | $7M | $7M | $1M | $146.0K | |
| Other Current Assets | $3M | $7M | $4M | $2M | $5M | $5M | $9M | $11M | · | · | · | |
| Current Assets | $615M | $320M | $235M | $99M | $163M | $230M | $185M | $202M | $150M | $152M | $161M | |
| PP&E (Net) | $7M | $10M | $13M | $17M | $22M | $29M | $36M | $40M | $27M | $9M | $3M | |
| PP&E (Gross) | $57M | $56M | $56M | $55M | $54M | $54M | $53M | $49M | $32M | $11M | $4M | |
| Accum. Depreciation | $50M | $46M | $43M | $38M | $32M | $25M | $17M | $10M | $4M | $2M | $2M | |
| Other Non-current Assets | $16.0K | $55.0K | $156.0K | · | · | · | · | · | · | · | · | |
| Total Assets | $638M | $352M | $275M | $146M | $207M | $279M | $284M | $296M | $182M | $165M | $165M | |
| Accounts Payable | $16M | $16M | $13M | $17M | $7M | $14M | $9M | $13M | $8M | $5M | $3M | |
| Accrued Liabilities | $7M | $5M | $2M | $4M | $4M | $2M | $5M | $6M | $3M | · | · | |
| Current Liabilities | $95M | $111M | $186M | $72M | $64M | $121M | $118M | $130M | $18M | $12M | $4M | |
| Capital Leases | $9M | $18M | $25M | $32M | $25M | $26M | $29M | · | · | $16.0K | $78.0K | |
| Other Non-current Liabilities | · | · | · | $190.0K | · | $474.0K | $2M | $2M | $2M | $796.0K | $163.0K | |
| Total Liabilities | $112M | $135M | $227M | $184M | $167M | $189M | $213M | $215M | $34M | $22M | $4M | |
| Common Stock | $1.62B | $1.18B | $935M | $803M | $750M | $694M | $540M | $375M | $310M | $216M | $185M | |
| Paid-in Capital | $228M | $156M | $129M | $119M | $88M | $72M | $57M | $38M | $22M | $10M | $3M | |
| Retained Earnings | $-1.33B | $-1.12B | $-1.02B | $-967M | $-806M | $-683M | $-533M | $-340M | $-193M | $-90M | $-35M | |
| AOCI | $-250.0K | $-262.0K | $-124.0K | $-29.0K | $181.0K | $389.0K | $267.0K | $153.0K | $116.0K | $-291.0K | $41.0K | |
| Stockholders' Equity | $518M | $210M | $40M | $-45M | $32M | $83M | $64M | $73M | $140M | $135M | $153M | |
| Liabilities + Equity | $638M | $352M | $275M | $146M | $207M | $279M | $284M | $296M | $182M | $165M | $165M | |
| Shares Outstanding | 187,660,263 | 153,037,286 | 119,162,234 | 86,924,643 | 59,841,116 | 48,778,678 | 34,340,690 | 29,472,197 | 27,829,079 | 23,502,169 | 21,551,423 |
Przepływy pieniężne 10
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | · | · | · | · | · | · | · | · | $2M | $784.0K | $594.0K | |
| Stock-based Comp | · | · | · | · | · | · | · | · | · | · | $4M | |
| Deferred Tax | $0 | $0 | $0 | · | · | · | · | · | $908.0K | $-698.0K | $36.0K | |
| Operating Cash Flow | $-187M | $-151M | $-19M | $-128M | $-89M | $-116M | $-188M | $-23M | $-84M | $-32M | $-13M | |
| CapEx | $718.0K | $938.0K | $1M | $1M | $560.0K | $1M | $4M | $10M | $19M | $6M | $2M | |
| Investing Cash Flow | $-718.0K | $-938.0K | $-1M | $-1M | $-560.0K | $-1M | $-4M | $-10M | $-19M | $-6M | · | |
| Stock Issued | · | · | $94M | $51M | · | $94M | $162M | $60M | $94M | $30M | $12M | |
| Financing Cash Flow | $488M | $254M | $133M | $67M | $56M | $155M | $164M | $65M | $94M | $29M | · | |
| Net Change in Cash | $300M | $102M | $112M | $-62M | $-34M | $37M | $-28M | $32M | $-8M | $-8M | $160M | |
| Taxes Paid | · | · | · | · | · | · | · | · | $-11.0K | $554.0K | · |
Stopy Wzrostu 3
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY | -60.6% | -4.4% | 3005.1% | -91.1% | 104.0% | · | · | · | · | · | · | |
| Revenue CAGR 3Y | 127.1% | 38.3% | 78.0% | · | · | · | · | · | · | · | · | |
| Revenue CAGR 5Y | 16.3% | · | · | · | · | · | · | · | · | · | · |
Wycena (TTM) 5
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $43M | $108M | $113M | $4M | $41M | $20M | $16M | $14M | $4M | $1M | $152.0K | |
| Net Income TTM | $-204M | $-97M | $-58M | $-162M | $-122M | $-150M | $-194M | $-147M | $-102M | $-56M | $-19M | |
| P/E | -14.0 | -17.7 | -9.4 | -3.4 | -1.3 | · | · | · | · | · | · | |
| P / Tangible Book | 6.2 | 9.0 | 15.2 | · | 5.8 | 4.6 | · | · | · | · | · | |
| Earnings Yield | -7.1% | -5.7% | -10.7% | -29.3% | -75.2% | · | · | · | · | · | · |
Rachunek zysków i strat 15
| Wskaźnik | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $2M | $38M | · | · | $9M | $9M | · | · | $20M | $13M | $49M | $22M | $13M | $285.0K | $375.0K | $2M | |
| R&D Expense | $51M | $47M | $53M | $46M | $43M | $41M | $45M | $41M | $40M | $33M | $32M | $33M | $31M | $28M | $30M | $27M | |
| SG&A Expense | $25M | $22M | $21M | $18M | $18M | $18M | $16M | $15M | $14M | $14M | $13M | $12M | $12M | $12M | $13M | $12M | |
| Operating Expenses | $76M | $70M | $74M | $64M | $61M | $59M | $61M | $56M | $55M | $47M | $45M | $46M | $43M | $39M | $43M | $40M | |
| Operating Income | $-74M | $-31M | $-56M | $-56M | $-53M | $-50M | $23M | $-64M | $-35M | $-34M | $4M | $-23M | $-30M | $-39M | $-42M | $-38M | |
| Interest Income | $5M | $5M | · | $2M | $2M | $3M | · | $2M | $2M | $3M | · | · | · | · | · | · | |
| Other Non-op | $-275.0K | $-80.0K | $234.0K | $324.0K | $-82.0K | $51.0K | $3M | $337.0K | $-18.0K | $365.0K | $171.0K | $118.0K | $1M | $-701.0K | $744.0K | $254.0K | |
| Pretax Income | $-69M | $-26M | $-53M | $-54M | $-50M | $-47M | $29M | $-62M | $-33M | $-32M | $7M | $-21M | $-27M | $-39M | $-41M | $-38M | |
| Income Tax | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $-677.0K | $0 | $0 | $0 | $0 | $0 | |
| Net Income | $-69M | $-26M | $-53M | $-54M | $-50M | $-47M | $29M | $-62M | $-33M | $-32M | $7M | $-21M | $-27M | $-39M | $-41M | $-38M | |
| EPS (Basic) | $-0.34 | $-0.13 | $-0.29 | $-0.32 | $-0.31 | $-0.29 | $0.26 | $-0.47 | $-0.25 | $-0.24 | $0.07 | $-0.20 | $-0.27 | $-0.42 | $-0.62 | $-0.62 | |
| EPS (Diluted) | $-0.34 | $-0.13 | $-0.29 | $-0.32 | $-0.31 | $-0.29 | $0.26 | $-0.47 | $-0.25 | $-0.24 | $0.07 | $-0.20 | $-0.27 | $-0.42 | $-0.62 | $-0.62 | |
| Shares (Basic) | 204,008,712 | 200,167,869 | -325,604,079 | 167,739,208 | 163,987,640 | 162,572,026 | -253,084,680 | 132,563,467 | 129,527,003 | 129,271,678 | 106,025,063 | 105,462,414 | 102,056,712 | 93,900,484 | 66,479,293 | 60,516,616 | |
| Shares (Diluted) | 204,008,712 | 200,167,869 | -325,604,079 | 167,739,208 | 163,987,640 | 162,572,026 | -253,084,680 | 132,563,467 | 129,527,003 | 129,271,678 | 106,975,231 | 105,462,414 | 102,056,712 | 93,900,484 | 66,479,293 | 60,516,616 | |
| EBITDA | $-74M | $-31M | · | $-56M | $-53M | $-50M | · | $-64M | $-35M | $-34M | $4M | $-23M | $-30M | $-39M | $-42M | $-38M |
Bilans 24
| Wskaźnik | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $368M | $545M | $602M | $196M | $208M | $243M | $302M | $311M | $154M | $181M | $140M | $173M | $208M | $97M | $123M | $62M | |
| Short-term Investments | · | · | · | · | · | · | · | · | · | · | · | · | · | $25M | $25M | $50M | |
| Receivables | $888.0K | $0 | $1M | $10M | $2M | · | $1M | $0 | $1M | $0 | $7M | · | · | · | · | · | |
| Prepaid Expense | $12M | $13M | $8M | $7M | $7M | $8M | $10M | $11M | $12M | $11M | $8M | $9M | $9M | $7M | $5M | $7M | |
| Other Current Assets | $4M | $3M | $3M | $3M | $7M | $7M | $7M | $3M | $5M | $5M | $4M | $3M | $3M | $2M | $7M | $6M | |
| Current Assets | $508M | $561M | $615M | $215M | $224M | $258M | $320M | $325M | $172M | $197M | $159M | $185M | $220M | $131M | $160M | $124M | |
| PP&E (Net) | $7M | $7M | $7M | $8M | $9M | $10M | $10M | $11M | $12M | $12M | $14M | $15M | $16M | $19M | $20M | $21M | |
| PP&E (Gross) | · | · | $57M | · | · | · | $56M | · | · | · | · | · | · | · | · | · | |
| Accum. Depreciation | $51M | $50M | $50M | $49M | $48M | $47M | $46M | $45M | $44M | $44M | $42M | $40M | $39M | · | · | · | |
| Other Non-current Assets | $667.0K | $386.0K | $16.0K | $22.0K | $728.0K | $448.0K | $55.0K | · | · | · | · | · | · | · | · | · | |
| Total Assets | $558M | $584M | $638M | $241M | $252M | $288M | $352M | $359M | $209M | $235M | $200M | $230M | $267M | $182M | $213M | $167M | |
| Accounts Payable | $20M | $19M | $16M | $14M | $15M | $14M | $16M | $13M | $18M | $12M | $13M | $12M | $12M | $16M | $11M | $10M | |
| Accrued Liabilities | $5M | $5M | $7M | $5M | $3M | $2M | $5M | $3M | $2M | $2M | $3M | $3M | $2M | $2M | $3M | $3M | |
| Current Liabilities | $51M | $50M | $95M | $86M | $87M | $87M | $111M | $171M | $173M | $166M | $100M | $140M | $133M | $64M | $64M | $58M | |
| Capital Leases | $40M | $7M | $9M | $11M | $14M | $16M | $18M | $20M | $22M | $24M | $27M | $29M | $31M | $34M | $35M | $24M | |
| Other Non-current Liabilities | · | · | · | · | · | · | · | · | · | · | · | $190.0K | $190.0K | · | · | $868.0K | |
| Total Liabilities | $105M | $72M | $112M | $109M | $105M | $109M | $135M | $209M | $204M | $202M | $233M | $274M | $294M | $178M | $174M | $160M | |
| Common Stock | $1.63B | $1.63B | $1.62B | $1.22B | $1.19B | $1.18B | $1.18B | $1.14B | $951M | $950M | $841M | $840M | $838M | $803M | $802M | $751M | |
| Paid-in Capital | $248M | $237M | $228M | $174M | $168M | $161M | $156M | $153M | $136M | $132M | $127M | $125M | $122M | $117M | $113M | $92M | |
| Retained Earnings | $-1.42B | $-1.35B | $-1.33B | $-1.27B | $-1.22B | $-1.17B | $-1.12B | $-1.15B | $-1.09B | $-1.06B | $-1.01B | $-1.02B | $-995M | $-924M | $-885M | $-843M | |
| AOCI | $-172.0K | $-254.0K | $-250.0K | $-190.0K | $-161.0K | $-204.0K | $-262.0K | $-159.0K | $-279.0K | $-198.0K | $-182.0K | $-150.0K | $-50.0K | $-123.0K | $-47.0K | $95.0K | |
| Stockholders' Equity | $454M | $512M | $518M | $125M | $139M | $172M | $210M | $142M | $-3M | $25M | $-40M | $-52M | $-35M | $-5M | $31M | $-53.0K | |
| Liabilities + Equity | $558M | $584M | $638M | $241M | $252M | $288M | $352M | $359M | $209M | $235M | $200M | $230M | $267M | $182M | $213M | $167M | |
| Shares Outstanding | 193,277,622 | 192,337,566 | 187,660,263 | 160,288,481 | 155,673,292 | 154,093,313 | 153,037,286 | 148,392,939 | 122,479,289 | 122,321,384 | 99,011,901 | 98,566,816 | 98,104,844 | 86,841,523 | 86,724,658 | 60,859,968 |
Przepływy pieniężne 8
| Wskaźnik | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $-54M | $-60M | $-34M | $-45M | $-46M | $-63M | $-44M | $-46M | $-27M | $-33M | $-34M | $-37M | $86M | $-26M | $-29M | $-40M | |
| CapEx | $884.0K | $438.0K | $-1.0K | $248.0K | $306.0K | $165.0K | $86.0K | $383.0K | $52.0K | $417.0K | $198.0K | $72.0K | $489.0K | $457.0K | $492.0K | $208.0K | |
| Investing Cash Flow | $-123M | $-438.0K | $1.0K | $-248.0K | $-306.0K | $-165.0K | $-86.0K | $-383.0K | $-52.0K | $-417.0K | $-198.0K | $-72.0K | $-489.0K | $-501.0K | $25M | $-50M | |
| Stock Issued | · | · | · | · | · | · | · | $174M | $0 | $14M | $-35M | $-35M | $0 | $-229.0K | · | · | |
| Net Stock Activity | · | · | · | · | · | · | · | · | · | $14M | · | · | $35M | · | · | · | |
| Financing Cash Flow | $330.0K | $3M | $440M | $33M | $12M | $4M | $35M | $204M | $653.0K | $15M | $2M | $2M | $35M | $17.0K | $66M | $1M | |
| Net Change in Cash | $-177M | $-57M | $406M | $-12M | $-35M | $-59M | $-9M | $157M | $-27M | $-19M | $-33M | $-36M | $120M | $-26M | $61M | $-89M | |
| Free Cash Flow | · | $-60M | · | · | · | $-63M | · | · | · | $-34M | · | · | $85M | · | · | $-40M |
Rentowność 7
| Wskaźnik | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | -3248.3% | -81.8% | · | · | -606.5% | -542.8% | · | · | -177.7% | -274.8% | 9.0% | -106.2% | -234.2% | -13648.8% | -11243.7% | -2176.8% | |
| Net Margin | -3052.6% | -68.2% | · | · | -580.2% | -510.9% | · | · | -167.2% | -251.7% | 14.7% | -95.5% | -212.0% | -13685.6% | -11012.3% | -2160.8% | |
| Pretax Margin | -3052.6% | -68.2% | · | · | -580.2% | -510.9% | · | · | -167.2% | -251.7% | 13.4% | -95.5% | -212.0% | -13685.6% | -11012.3% | -2160.8% | |
| EBITDA Margin | -3248.3% | -81.8% | · | · | -606.5% | -542.8% | · | · | -177.7% | -274.8% | 9.0% | -106.2% | -234.2% | -13648.8% | -11243.7% | -2176.8% | |
| ROA | -17.1% | -6.0% | · | -17.9% | -21.9% | -17.9% | · | -22.1% | -15.0% | -12.6% | 3.8% | -9.5% | -12.6% | -20.4% | -19.7% | -18.4% | |
| ROE | -23.4% | -7.6% | · | -40.5% | -74.3% | -47.5% | · | -122.2% | 119.3% | 676.9% | -32.2% | 203.2% | 157.7% | -307.3% | -156.5% | -143.3% | |
| ROIC | -16.3% | -6.1% | · | -45.2% | -37.9% | -29.0% | · | -45.1% | 1006.5% | -135.7% | -12.1% | 45.4% | 87.2% | 860.8% | -136.2% | 71875.5% |
Płynność i wypłacalność 2
| Wskaźnik | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 10.0 | 11.3 | · | 2.5 | 2.6 | 3.0 | · | 1.9 | 1.0 | 1.2 | 1.6 | 1.3 | 1.7 | 2.0 | 2.5 | 2.1 | |
| Quick Ratio | 7.3 | 10.9 | · | 2.4 | 2.4 | 2.8 | · | 1.8 | 0.9 | 1.1 | 1.5 | 1.2 | 1.6 | 1.9 | 2.3 | 1.9 |
Efektywność 2
| Wskaźnik | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.0 | 0.1 | · | · | 0.0 | 0.0 | · | · | 0.1 | 0.0 | 0.3 | 0.1 | 0.1 | 0.0 | 0.0 | 0.0 | |
| Receivables Turnover | 1.8 | · | · | · | 6.0 | · | · | · | 30.5 | 0.8 | 3.3 | · | · | · | · | · |
Wycena (TTM) 10
| Wskaźnik | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | · | · | · | · | · | · | · | $104M | $104M | $97M | $85M | $36M | $15M | $39M | $41M | · | |
| Net Income TTM | $-200M | $-177M | · | $-213M | $-192M | $-173M | · | $-119M | $-78M | $-73M | $-80M | $-129M | $-146M | $-124M | $-124M | $-125M | |
| Market Cap | $1.12B | $1.39B | · | $1.17B | $1.01B | $1.25B | · | $1.22B | $611M | $755M | $569M | $359M | $425M | $313M | $282M | $122M | |
| P/E | -5.3 | -6.9 | · | -5.3 | -4.9 | -6.5 | · | -9.2 | -8.0 | -9.6 | -7.0 | -2.4 | -2.2 | -2.0 | -1.5 | · | |
| P/S | · | · | · | · | · | · | · | 11.8 | 5.9 | 7.8 | 6.7 | 10.1 | 27.7 | 8.1 | 6.8 | · | |
| P/B | 2.5 | 2.7 | · | 9.4 | 7.3 | 7.2 | · | 8.6 | -175.8 | 29.7 | -14.1 | -6.9 | -12.2 | -69.4 | 9.1 | -2296.6 | |
| P / Tangible Book | 2.5 | 2.7 | · | 9.4 | 7.3 | 7.2 | · | 8.6 | · | 29.7 | · | · | · | · | 9.1 | · | |
| P / Cash Flow | · | -23.4 | · | · | · | -19.8 | · | · | · | -22.6 | · | · | 5.0 | · | · | -3.1 | |
| P / FCF | · | -23.2 | · | · | · | -19.7 | · | · | · | -22.3 | · | · | 5.0 | · | · | -3.0 | |
| Earnings Yield | -18.9% | -14.5% | · | -19.0% | -20.3% | -15.5% | · | -10.8% | -12.4% | -10.4% | -14.3% | -41.5% | -44.6% | -49.3% | -65.8% | · |
Sprawozdania finansowe Rachunek zysków i strat, bilans, przepływy pieniężne — roczne, ostatnie 5 lat
Rachunek zysków i strat
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Przychody | $43M | $108M | $113M | $4M | $41M |
| Zysk netto | $-204M | $-97M | $-58M | $-162M | $-122M |
| Rozwodniony EPS | $-1.21 | $-0.70 | $-0.54 | $-2.05 | $-2.36 |
Najnowsze wiadomości Najnowsze nagłówki wspominające o tej firmie
Moje wskaźniki Twoja osobista lista obserwowanych — wybrane wiersze z Pełnych Fundamentów
📊
Wybierz metryki, które są dla Ciebie ważne — kliknij ➕ obok dowolnego wiersza w Pełnych Fundamentach powyżej.
Twój wybór został zapisany i będzie Ci towarzyszył we wszystkich tickerach.
Właściciele instytucjonalni (13F) 264 emitenci · $892.5M łącznie · Na dzień 30 czerwca 2026
Instytucje, które zgłaszają posiadanie tych akcji w swoich kwartalnych zgłoszeniach SEC Form 13F. Tylko pozycje długie; pojedynczy zgłaszający może pojawić się dwukrotnie dla oddzielnych transz opcji. Duże przeciwstawne pozycje put/call zazwyczaj odzwierciedlają działalność market-makingową lub zabezpieczone zapasy, a nie przekonanie kierunkowe.
Aktywność instytucjonalna — Q2 2026 vs poprzedni kwartał
| Nowe pozycje | Zamknięte pozycje | Zwiększone | Zmniejszony | Zmiana liczby akcji netto |
|---|---|---|---|---|
| 56 (+5 vs poprzedni kw.) | 37 (+1 vs poprzedni kw.) | 93 (-18 vs poprzedni kw.) | 59 (+4 vs poprzedni kw.) | +16.8M |
Porównano z Q1 2026. Zgłoszenia SEC Form 13F są wymagane w ciągu 45 dni od końca kwartału plus krótki bufor dla spóźnionych zgłoszeń — kwartały mieszczące się jeszcze w tym terminie są pomijane na rzecz ostatniej w pełni zgłoszonej pary.
| Instytucja | Wartość | Akcje | % z śledzonych 13F | Typ |
|---|---|---|---|---|
| RA CAPITAL MANAGEMENT, L.P. | $156 727 684 | 26 975 505 | 17,56% | Akcje |
| GSK plc | $106 007 465 | 18 245 691 | 11,88% | Akcje |
| MAVERICK CAPITAL LTD | $59 715 848 | 10 278 115 | 6,69% | Akcje |
| Driehaus Capital Management LLC | $31 624 661 | 5 443 143 | 3,54% | Akcje |
| PRIMECAP MANAGEMENT CO/CA/ | $31 110 354 | 5 354 622 | 3,49% | Akcje |
| 683 Capital Management, LLC | $28 759 500 | 4 950 000 | 3,22% | Akcje |
| STATE STREET CORP | $28 116 432 | 4 839 317 | 3,15% | Akcje |
| READYSTATE ASSET MANAGEMENT LP | $27 464 678 | 4 727 139 | 3,08% | Akcje |
| M28 Capital Management LP | $26 657 930 | 4 588 284 | 2,99% | Akcje |
| TWO SIGMA INVESTMENTS, LP | $21 541 656 | 3 707 686 | 2,41% | Akcje |
| GEODE CAPITAL MANAGEMENT, LLC | $19 277 729 | 3 317 246 | 2,16% | Akcje |
| FMR LLC | $17 099 004 | 2 943 030 | 1,92% | Akcje |
| ALGERT GLOBAL LLC | $16 370 343 | 2 817 615 | 1,83% | Akcje |
| Qube Research & Technologies Ltd | $16 128 560 | 2 776 000 | 1,81% | Akcje |
| Squarepoint Ops LLC | $14 765 778 | 2 541 442 | 1,65% | Akcje |
| VANGUARD GROUP INC | $14 386 233 | 846 249 | 1,61% | Akcje |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $12 263 463 | 2 110 751 | 1,37% | Akcje |
| MORGAN STANLEY | $12 000 799 | 2 065 542 | 1,34% | Akcje |
| Pfizer Inc | $10 931 250 | 1 875 000 | 1,22% | Akcje |
| MILLENNIUM MANAGEMENT LLC | $10 523 548 | 1 811 282 | 1,18% | Akcje |
| D. E. Shaw & Co., Inc. | $10 296 645 | 1 772 228 | 1,15% | Akcje |
| VANGUARD CAPITAL MANAGEMENT LLC | $10 175 651 | 1 751 403 | 1,14% | Akcje |
| SCHRODER INVESTMENT MANAGEMENT GROUP | $9 920 932 | 1 746 643 | 1,11% | Akcje |
| RENAISSANCE TECHNOLOGIES LLC | $9 903 261 | 1 704 520 | 1,11% | Akcje |
| DIMENSIONAL FUND ADVISORS LP | $9 201 210 | 1 583 685 | 1,03% | Akcje |
| GOLDMAN SACHS GROUP INC | $8 877 262 | 1 527 928 | 0,99% | Akcje |
| Point72 Asset Management, L.P. | $8 627 786 | 1 484 989 | 0,97% | Akcje |
| RTW INVESTMENTS, LP | $7 843 500 | 1 350 000 | 0,88% | Akcje |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $7 114 025 | 1 224 445 | 0,80% | Akcje |
| EMERALD ADVISERS, LLC | $7 111 237 | 1 223 965 | 0,80% | Akcje |
| BlackRock, Inc. | $5 539 777 | 953 490 | 0,62% | Akcje |
| SymBiosis Capital Partners, LLC | $5 437 500 | 750 000 | 0,61% | Akcje |
| Pictet Asset Management Holding SA | $5 330 146 | 917 409 | 0,60% | Akcje |
| VANGUARD FIDUCIARY TRUST CO | $5 157 403 | 887 677 | 0,58% | Akcje |
| Aberdeen Group plc | $5 092 221 | 876 458 | 0,57% | Akcje |
| EMERALD MUTUAL FUND ADVISERS TRUST | $4 926 874 | 847 999 | 0,55% | Akcje |
| BAKER BROS. ADVISORS LP | $4 779 527 | 822 638 | 0,54% | Akcje |
| BNP PARIBAS FINANCIAL MARKETS | $4 712 241 | 811 057 | 0,53% | Akcje |
| CAPITAL FUND MANAGEMENT S.A. | $4 268 874 | 734 746 | 0,48% | Akcje |
| SPHERA FUNDS MANAGEMENT LTD. | $3 708 360 | 638 272 | 0,42% | Akcje |
| Y-Intercept (Hong Kong) Ltd | $3 544 646 | 610 094 | 0,40% | Akcje |
| Susquehanna Portfolio Strategies, LLC | $3 533 607 | 608 194 | 0,40% | Akcje |
| TANG CAPITAL MANAGEMENT LLC | $3 486 000 | 600 000 | 0,39% | Akcje |
| Walleye Capital LLC | $3 401 482 | 585 453 | 0,38% | Akcje |
| CITADEL ADVISORS LLC | $2 789 695 | 480 154 | 0,31% | Akcje |
| BANK OF AMERICA CORP /DE/ | $2 569 042 | 442 176 | 0,29% | Akcje |
| XTX Topco Ltd | $2 556 011 | 439 933 | 0,29% | Akcje |
| Universal- Beteiligungs- und Servicegesellschaft mbH | $2 375 674 | 408 894 | 0,27% | Akcje |
| Connor, Clark & Lunn Investment Management Ltd. | $2 319 398 | 399 208 | 0,26% | Akcje |
| Trexquant Investment LP | $2 208 782 | 380 169 | 0,25% | Akcje |
| HSBC HOLDINGS PLC | $2 172 683 | 370 449 | 0,24% | Akcje |
| Woodline Partners LP | $2 036 585 | 350 531 | 0,23% | Akcje |
| Ishara Investments LP | $1 905 680 | 328 000 | 0,21% | Akcje |
| BARCLAYS PLC | $1 766 839 | 304 103 | 0,20% | Akcje |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $1 739 514 | 299 400 | 0,19% | Akcje |
| PLATINUM INVESTMENT MANAGEMENT LTD | $1 599 313 | 275 269 | 0,18% | Akcje |
| JPMORGAN CHASE & CO | $1 543 989 | 265 614 | 0,17% | Akcje |
| Swiss National Bank | $1 514 086 | 260 600 | 0,17% | Akcje |
| ExodusPoint Capital Management, LP | $1 458 728 | 251 072 | 0,16% | Akcje |
| Privium Fund Management B.V. | $1 400 268 | 241 010 | 0,16% | Akcje |
| F/m Investments LLC | $1 365 844 | 235 085 | 0,15% | Akcje |
| MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. | $1 339 112 | 230 484 | 0,15% | Akcje |
| Newtyn Management, LLC | $1 249 150 | 215 000 | 0,14% | Akcje |
| TD Asset Management Inc | $1 127 291 | 194 026 | 0,13% | Akcje |
| ALPS ADVISORS INC | $1 125 780 | 193 766 | 0,13% | Akcje |
| RHUMBLINE ADVISERS | $1 125 195 | 193 667 | 0,13% | Akcje |
| Sofinnova Investments, Inc. | $1 099 560 | 189 253 | 0,12% | Akcje |
| CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM | $1 052 744 | 145 206 | 0,12% | Akcje |
| Elmind Capital, LP | $1 033 285 | 177 846 | 0,12% | Akcje |
| ADAR1 Capital Management, LLC | $929 600 | 160 000 | 0,10% | Akcje |
| Bank of New York Mellon Corp | $911 560 | 156 895 | 0,10% | Akcje |
| ALLIANCEBERNSTEIN L.P. | $904 293 | 124 730 | 0,10% | Akcje |
| Burkehill Global Management, LP | $871 500 | 150 000 | 0,10% | Akcje |
| BOOTHBAY FUND MANAGEMENT, LLC | $842 450 | 145 000 | 0,09% | Akcje |
| MANUFACTURERS LIFE INSURANCE COMPANY, THE | $836 692 | 144 009 | 0,09% | Akcje |
| STATE OF WISCONSIN INVESTMENT BOARD | $830 981 | 143 026 | 0,09% | Akcje |
| WELLINGTON MANAGEMENT GROUP LLP | $801 995 | 138 037 | 0,09% | Akcje |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $775 635 | 133 500 | 0,09% | Opcja kupna |
| CITIGROUP INC | $680 287 | 117 089 | 0,08% | Akcje |
| WELLS FARGO & COMPANY/MN | $675 395 | 116 247 | 0,08% | Akcje |
| James J. Burns & Company, LLC | $666 988 | 114 800 | 0,07% | Akcje |
| IEQ CAPITAL, LLC | $618 451 | 106 446 | 0,07% | Akcje |
| Cetera Investment Advisers | $609 341 | 104 878 | 0,07% | Akcje |
| LOS ANGELES CAPITAL MANAGEMENT LLC | $608 336 | 104 705 | 0,07% | Akcje |
| VANGUARD ASSET MANAGEMENT, Ltd | $604 211 | 103 995 | 0,07% | Akcje |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $593 782 | 102 200 | 0,07% | Opcja sprzedaży |
| Mariner, LLC | $593 759 | 102 195 | 0,07% | Akcje |
| Bridgefront Capital, LLC | $589 448 | 101 454 | 0,07% | Akcje |
| UBS Group AG | $531 034 | 91 400 | 0,06% | Opcja kupna |
| MetLife Investment Management, LLC | $513 587 | 88 397 | 0,06% | Akcje |
| Ikarian Capital, LLC | $495 507 | 85 285 | 0,06% | Akcje |
| NOMURA ASSET MANAGEMENT INTERNATIONAL INC. | $476 000 | 81 955 | 0,05% | Akcje |
| Entropy Technologies, LP | $467 409 | 80 449 | 0,05% | Akcje |
| EXCHANGE TRADED CONCEPTS, LLC | $467 310 | 80 432 | 0,05% | Akcje |
| Quadrature Capital Ltd | $459 368 | 79 065 | 0,05% | Akcje |
| SUSQUEHANNA FUNDAMENTAL INVESTMENTS, LLC | $451 007 | 77 626 | 0,05% | Akcje |
| a16z Perennial Management, L.P. | $450 966 | 77 619 | 0,05% | Akcje |
| MARSHALL WACE, LLP | $443 645 | 76 359 | 0,05% | Akcje |
| Zurcher Kantonalbank (Zurich Cantonalbank) | $432 450 | 74 432 | 0,05% | Akcje |
| FEDERATED HERMES, INC. | $408 304 | 70 276 | 0,05% | Akcje |
Insiderzy spółki 21 insiderów · 8 dyrektorzy generalni · 9 dyrektorzy
| Insider | Rola | Ostatnia aktywność | Posiadane akcje | Kupna 12m | Sprzedaże 12m | Netto 12m |
|---|---|---|---|---|---|---|
| Paul Bolno | President and CEO | 5 lutego 2026 A | 275 520 | 0 | 2 | $-2 336 201 |
| Kyle Moran | Chief Financial Officer | 5 lutego 2026 A | 134 385 | 0 | 7 | $-4 151 988 |
| David G Gaiero | Interim CFO | 3 marca 2020 A | 6 392 | 0 | 0 | $0 |
| Keith Regnante | Chief Financial Officer | 7 marca 2019 A | 29 186 | 0 | 0 | $0 |
| Chris Francis | SVP, Corporate Development, Head of Emerging Areas | 26 lutego 2026 M | 61 867 | 0 | 14 | $-7 103 233 |
| Chandra Vargeese | Chief Technology Officer, Head of Platform Discovery Sciences | 5 lutego 2026 A | 408 246 | 0 | 1 | $-43 417 |
| Michael A. Panzara | Chief Medical Officer, Head of Therapeutics Discovery and Development | 25 lipca 2022 A | 109 103 | 0 | 0 | $0 |
| Mark Baldry | Chief Commerical Officer | 5 sierpnia 2019 A | 39 000 | 0 | 0 | $0 |
| Gregory L. Verdine | Dyrektor | 8 grudnia 2025 S | 275 217 | 0 | 3 | $-369 461 |
| Christian O Henry | Dyrektor | 8 grudnia 2025 M | 12 700 | 0 | 4 | $-1 369 324 |
| Mark Corrigan | Dyrektor | 8 grudnia 2025 S | 28 815 | 0 | 2 | $-217 265 |
| Amy Pott | Dyrektor | 18 sierpnia 2020 A | — | 0 | 0 | $0 |
| Peter Kolchinsky | Dyrektor | 18 sierpnia 2020 A | — | 0 | 0 | $0 |
| Koji Miura | Dyrektor | 15 sierpnia 2019 A | — | 0 | 0 | $0 |
| Masaharu Tanaka | Dyrektor | 10 listopada 2016 A | — | 0 | 0 | $0 |
| Takeshi Wada | Dyrektor | 10 listopada 2016 A | — | 0 | 0 | $0 |
| Adrian Rawcliffe | — | 12 sierpnia 2026 S | 0 | 0 | 3 | $-806 604 |
| Tan Aik Na | — | 11 sierpnia 2026 S | 24 968 | 0 | 10 | $-2 020 004 |
| Ken Takanashi | — | 11 sierpnia 2026 S | 20 079 | 0 | 1 | $-23 223 |
| Heidi L Wagner | — | 11 sierpnia 2026 M | 44 930 | 0 | 3 | $-231 070 |
| Roberto Guerciolini | — | 7 grudnia 2016 M | 4 000 | 0 | 0 | $0 |
Insiderzy z zgłoszeń SEC Form 3/4/5; netto = tylko otwarty rynek P/S
Aktywiści i właściciele 5%+ 4 akcje
Inwestorzy, którzy złożyli SEC Schedule 13D — posiadanie beneficjentów powyżej 5% z zamiarem wpływania na emitenta (udziały aktywistów, kampanie zarządu, M&A). Każdy wiersz pokazuje najnowszy znany stan pozycji tego zgłaszającego.
| Zgłaszający | Złożono | Udział | Status | Cel | Zgłoszenie |
|---|---|---|---|---|---|
| RA Capital Management, L.P., Peter Kolchinsky, Rajeev Shah, RA Capital Healthcare Fund, L.P. ×9 zgłoszenia | 11 sierpnia 2026 | 16,80% | Aneks | — | SEC |
| Shin Nippon Biomedical Laboratories, Ltd., SNBL USA, Ltd., Ken Takanashi ×6 zgłoszenia | 12 sierpnia 2022 | — | Pierwotne zgłoszenie | — | SEC |
| Kagoshima Shinsangyo Sousei Investment Limited Partnership, Kagoshima Development Co. Ltd. ×5 zgłoszenia | 20 lipca 2022 | — | Pierwotne zgłoszenie | — | SEC |
| RA Capital Management, LLC, Peter Kolchinsky ×3 zgłoszenia | 28 stycznia 2019 | — | Pierwotne zgłoszenie | — | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
Posiadanie ETF-ów Posiadane przez 28 funduszy ETF
Waga odzwierciedla wyłącznie bezpośrednie udziały kapitałowe (N-PORT); fundusze oparte na dźwigni lub instrumentach pochodnych mogą posiadać dodatkowe ekspozycje na swapy, które nie są pokazane.
| Fundusz | Waga | Jednostki | Na dzień | Źródło |
|---|---|---|---|---|
| GNOM · Global X Funds | 1,03% | 87 259 NS | 31 maja 2026 | N-PORT |
| PILL · Direxion Shares ETF Trust | 0,67% | 12 254 NS | 30 kwietnia 2026 | N-PORT |
| IHE · iShares Trust | 0,20% | 541 635 SH | 8 sierpnia 2026 | Dziennie |
| IWC · iShares Trust | 0,19% | 463 783 SH | 8 sierpnia 2026 | Dziennie |
| IBB · iShares Trust | 0,07% | 1 158 886 SH | 8 sierpnia 2026 | Dziennie |
| VTWV · VANGUARD SCOTTSDALE FUNDS | 0,05% | 111 824 SH | 8 sierpnia 2026 | Dziennie |
| IWN · iShares Trust | 0,05% | 1 196 960 SH | 8 sierpnia 2026 | Dziennie |
| RSSL · Global X Funds | 0,03% | 60 562 NS | 30 kwietnia 2026 | N-PORT |
| IWM · iShares Trust | 0,03% | 3 525 539 SH | 8 sierpnia 2026 | Dziennie |
| VTWO · VANGUARD SCOTTSDALE FUNDS | 0,02% | 793 588 SH | 8 sierpnia 2026 | Dziennie |
| ISCV · iShares Trust | 0,02% | 18 901 SH | 8 sierpnia 2026 | Dziennie |
| ISCB · iShares Trust | 0,01% | 6 085 SH | 8 sierpnia 2026 | Dziennie |
| DFAS · Dimensional ETF Trust | 0,01% | 250 409 NS | 30 kwietnia 2026 | N-PORT |
| VXF · VANGUARD INDEX FUNDS | 0,01% | 1 751 403 SH | 8 sierpnia 2026 | Dziennie |
| VHT · VANGUARD WORLD FUND | 0,01% | 390 910 SH | 8 sierpnia 2026 | Dziennie |
| ISCG · iShares Trust | 0,01% | 14 793 SH | 8 sierpnia 2026 | Dziennie |
| WSML · iShares Trust | 0,01% | 7 226 SH | 8 sierpnia 2026 | Dziennie |
| MSSM · MORGAN STANLEY PATHWAY FUNDS | 0,00% | 4 467 NS | 31 maja 2026 | N-PORT |
| IWO · iShares Trust | 0,00% | 86 005 SH | 8 sierpnia 2026 | Dziennie |
| DFAU · Dimensional ETF Trust | 0,00% | 43 085 NS | 30 kwietnia 2026 | N-PORT |
| DXUV · Dimensional ETF Trust | 0,00% | 1 463 NS | 30 kwietnia 2026 | N-PORT |
| DCOR · Dimensional ETF Trust | 0,00% | 10 250 NS | 30 kwietnia 2026 | N-PORT |
| IWV · iShares Trust | 0,00% | 63 707 SH | 8 sierpnia 2026 | Dziennie |
| ITOT · iShares Trust | 0,00% | 248 385 SH | 8 sierpnia 2026 | Dziennie |
| DFAC · Dimensional ETF Trust | 0,00% | 74 011 NS | 30 kwietnia 2026 | N-PORT |
| DFUS · Dimensional ETF Trust | 0,00% | 18 648 NS | 30 kwietnia 2026 | N-PORT |
| VTWG · VANGUARD SCOTTSDALE FUNDS | 0,00% | 10 069 SH | 8 sierpnia 2026 | Dziennie |
| VTHR · VANGUARD SCOTTSDALE FUNDS | 0,00% | 11 431 SH | 8 sierpnia 2026 | Dziennie |